Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 7 studies | 44% ± 16% | |
adipocyte | 6 studies | 28% ± 5% | |
smooth muscle cell | 5 studies | 27% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 41% ± 20% | |
club cell | 4 studies | 35% ± 13% | |
hepatocyte | 3 studies | 41% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 4553.91 | 243 / 245 | 95% | 70.93 | 478 / 502 |
liver | 100% | 2961.50 | 226 / 226 | 90% | 26.75 | 365 / 406 |
intestine | 86% | 1111.23 | 832 / 966 | 91% | 21.74 | 480 / 527 |
esophagus | 93% | 1414.61 | 1343 / 1445 | 75% | 13.28 | 137 / 183 |
uterus | 95% | 2845.95 | 162 / 170 | 58% | 17.29 | 266 / 459 |
stomach | 60% | 702.92 | 217 / 359 | 79% | 19.89 | 226 / 286 |
adrenal gland | 100% | 2365.80 | 258 / 258 | 35% | 10.57 | 81 / 230 |
bladder | 86% | 1009.38 | 18 / 21 | 47% | 9.28 | 237 / 504 |
lung | 61% | 1460.91 | 350 / 578 | 71% | 21.80 | 816 / 1155 |
ovary | 99% | 3354.76 | 179 / 180 | 7% | 0.64 | 28 / 430 |
kidney | 42% | 394.62 | 37 / 89 | 61% | 8.03 | 548 / 901 |
blood vessel | 99% | 7269.34 | 1326 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 6290.09 | 773 / 803 | 0% | 0 | 0 / 0 |
skin | 74% | 1230.20 | 1330 / 1809 | 14% | 1.86 | 66 / 472 |
pancreas | 0% | 1.82 | 1 / 328 | 85% | 20.62 | 151 / 178 |
breast | 69% | 1013.15 | 316 / 459 | 13% | 1.10 | 145 / 1118 |
adipose | 78% | 1118.70 | 937 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 6.92 | 17 / 29 |
brain | 5% | 37.48 | 127 / 2642 | 30% | 3.07 | 212 / 705 |
thymus | 16% | 159.33 | 104 / 653 | 17% | 1.35 | 102 / 605 |
tonsil | 0% | 0 | 0 / 0 | 29% | 5.07 | 13 / 45 |
heart | 2% | 10.78 | 14 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 4.16 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015844 | Biological process | monoamine transport |
GO_0015695 | Biological process | organic cation transport |
GO_0015697 | Biological process | quaternary ammonium group transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0090494 | Biological process | dopamine uptake |
GO_0006811 | Biological process | monoatomic ion transport |
GO_1903711 | Biological process | spermidine transmembrane transport |
GO_1990748 | Biological process | cellular detoxification |
GO_0032098 | Biological process | regulation of appetite |
GO_0048241 | Biological process | epinephrine transport |
GO_0015872 | Biological process | dopamine transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_0051620 | Biological process | norepinephrine uptake |
GO_0001692 | Biological process | histamine metabolic process |
GO_0006837 | Biological process | serotonin transport |
GO_0015711 | Biological process | organic anion transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0015874 | Biological process | norepinephrine transport |
GO_0051610 | Biological process | serotonin uptake |
GO_0051608 | Biological process | histamine transport |
GO_0072530 | Biological process | purine-containing compound transmembrane transport |
GO_0015718 | Biological process | monocarboxylic acid transport |
GO_0051625 | Biological process | epinephrine uptake |
GO_0051615 | Biological process | histamine uptake |
GO_0015848 | Biological process | spermidine transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0016020 | Cellular component | membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005640 | Cellular component | nuclear outer membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015101 | Molecular function | organic cation transmembrane transporter activity |
GO_0015651 | Molecular function | quaternary ammonium group transmembrane transporter activity |
GO_0005326 | Molecular function | neurotransmitter transmembrane transporter activity |
GO_0008504 | Molecular function | monoamine transmembrane transporter activity |
GO_0015606 | Molecular function | spermidine transmembrane transporter activity |
GO_0019534 | Molecular function | toxin transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC22A3 |
Protein name | Extraneuronal monoamine transporter (EMT) Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3) (OCT3) Organic cation transporter 3 |
Synonyms | EMTH OCT3 |
Description | FUNCTION: Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics . Cation cellular uptake or release is driven by the electrochemical potential, i.e. membrane potential and concentration gradient . Functions as a Na(+)- and Cl(-)-independent, bidirectional uniporter . Implicated in monoamine neurotransmitters uptake such as dopamine, adrenaline/epinephrine, noradrenaline/norepinephrine, histamine, serotonin and tyramine, thereby supporting a role in homeostatic regulation of aminergic neurotransmission in the brain . Transports dopaminergic neuromodulators cyclo(his-pro) and salsolinol with low efficiency . May be involved in the uptake and disposition of cationic compounds by renal clearance from the blood flow . May contribute to regulate the transport of cationic compounds in testis across the blood-testis-barrier (Probable). Mediates the transport of polyamine spermidine and putrescine (By similarity). Mediates the bidirectional transport of polyamine agmatine . Also transports guanidine . May also mediate intracellular transport of organic cations, thereby playing a role in amine metabolism and intracellular signaling (By similarity). . |
Accessions | Q96KH7 O75751 Q9NQC0 ENST00000275300.3 |